ATI Neuro Part 2 – Study
Guide & Practice Questions
Page 1 Guidehttps://www.stuvia.com/dashboard!@_)#*)(@$)($@*($@)($@*_ ATI Neuro Part 2 – Study Guide & Practice Questions.pdf
, ATI Neuro Part 2 2026-03-04
A patient is to start taking amitriptyline. For which of the following should the health care provider instruct the patient to
monitor and report?
Blurred vision, urinary hesitancy, tachycardia.
Early clinical manifestations of lithium ( Lithobid) toxicity include which of the following?
Nausea, muscle weakness.
During an assessment of a patient taking chlorpromazine, the provider notes a slow shuffling gait, rigid facial expression,
and fine tremors. The provider recognizes this as which of the following?
Parkinsonism
Which of the following drugs to treat glaucoma by lowering intraocular pressure is a beta-adrenergic receptor blocker?
Betaxolol (Betoptic)
Match the drug classification in the left column with its therapeutic use in the right column.
*Bezodiasepines- Anxiety disorders
*Monoamine oxidase inhibitors- Depression.
*Antipsychotics- Schizophrenia.
* Cholinergic Agonists- Glaucoma
Page 2 ATI Neuro Part 2.pdf